SBIR/STTR awards granted by National Institutes of Health | 8,409 results

where

Government Branch

National Institutes of Health

Save querySave query

Access by APIAccess by API

Name	Description	SBIR/STTR Award Recipient	Government Branch	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
‌ NeoVative, Inc. STTR Phase II Award, February 2019	A STTR Phase II contract was awarded to NeoVative, Inc. in February, 2019 for $723,986.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ NeoVative, Inc.	National Institutes of Health	STTR	2R42GM113463-02	Phase II	723,986	February 1, 2019	sbir.gov/node/1678345
‌ DEKK-TEC INC SBIR Phase II Award, September 2018	A SBIR Phase II contract was awarded to DEKK-TEC INC in September, 2018 for $759,848.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ DEKK-TEC INC	National Institutes of Health	SBIR	2R44CA203351-03	Phase II	759,848	September 24, 2018	sbir.gov/node/1568873
‌ TROPHOGEN INC SBIR Phase II Award, March 2018	A SBIR Phase II contract was awarded to Trophogen, Inc. in March, 2018 for $1,768,121.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Trophogen, Inc.	National Institutes of Health	SBIR	4R44HD090804-02	Phase II	1,768,121	March 1, 2018	sbir.gov/node/1571445
‌ Solid Material Solutions, LLC SBIR Phase I Award, September 2018	A SBIR Phase I contract was awarded to Solid Material Solutions, LLC in September, 2018 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Solid Material Solutions, LLC	National Institutes of Health	SBIR	1R43EB027531-01	Phase I	225,000	September 30, 2018	sbir.gov/node/1572397
‌ BENDER TECH, LLC SBIR Phase I Award, July 2019	A SBIR Phase I contract was awarded to BENDER TECH, LLC in July, 2019 for $142,309.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	BENDER TECH, LLC	National Institutes of Health	SBIR	1R43MD014073-01	Phase I	142,309	July 15, 2019	sbir.gov/node/1682417
‌ Neurowave Systems Inc. SBIR Phase II Award, September 2019	A SBIR Phase II contract was awarded to Neurowave Systems Inc. in September, 2019 for $663,684.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Neurowave Systems Inc.	National Institutes of Health	SBIR	2R44GM112358-02	Phase II	663,684	September 16, 2019	sbir.gov/node/1685053
‌ ARIMA GENOMICS LLC SBIR Phase II Award, April 2021	A SBIR Phase II contract was awarded to Arima Genomics, Inc. in April, 2021 for $1,074,115.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Arima Genomics, Inc.	National Institutes of Health	SBIR	1R44GM142410-01	Phase II	1,074,115	April 5, 2021	sbir.gov/node/2188761
‌ ARIMA GENOMICS LLC SBIR Phase II Award, September 2021	A SBIR Phase II contract was awarded to Arima Genomics, Inc. in September, 2021 for $1,085,125.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Arima Genomics, Inc.	National Institutes of Health	SBIR	1R44HG011897-01	Phase II	1,085,125	September 10, 2021	sbir.gov/node/2189337
‌ TROPHOGEN INC SBIR Phase II Award, September 2019	A SBIR Phase II contract was awarded to Trophogen, Inc. in September, 2019 for $778,770.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Trophogen, Inc.	National Institutes of Health	SBIR	4R44CA224376-02	Phase II	778,770	September 1, 2019	sbir.gov/node/1686769
‌ ARIMA GENOMICS LLC SBIR Phase II Award, March 2018	A SBIR Phase II contract was awarded to Arima Genomics, Inc. in March, 2018 for $1,747,389.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Arima Genomics, Inc.	National Institutes of Health	SBIR	2R44HG008118-04A1	Phase II	1,747,389	March 2, 2018	sbir.gov/node/1565531
‌ SERINA THERAPEUTICS INC SBIR Phase I Award, September 2019	A SBIR Phase I contract was awarded to Serina Therapeutics in September, 2019 for $1,658,634.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Serina Therapeutics	National Institutes of Health	SBIR	1R44NS115196-01	Phase I	1,658,634	September 30, 2019	sbir.gov/node/1685881
‌ SAFELYYOU INC. SBIR Phase II Award, September 2019	A SBIR Phase II contract was awarded to SafelyYou in September, 2019 for $536,666.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	SafelyYou	National Institutes of Health	SBIR	4R44AG062088-02	Phase II	536,666	September 15, 2019	sbir.gov/node/1686717
‌ TROPHOGEN INC SBIR Phase I Award, August 2018	A SBIR Phase I contract was awarded to Trophogen, Inc. in August, 2018 for $285,070.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Trophogen, Inc.	National Institutes of Health	SBIR	1R44CA224376-01A1	Phase I	285,070	August 1, 2018	sbir.gov/node/1567679
‌ COLLABORATIONS PHARMACEUTICALS, INC. SBIR Phase I Award, August 2019	A SBIR Phase I contract was awarded to Collaborations Pharmaceuticals in August, 2019 for $68,862.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Collaborations Pharmaceuticals	National Institutes of Health	SBIR	1R43AT010585-01	Phase I	68,862	August 15, 2019	sbir.gov/node/1684517
‌ NUBAD, LLC STTR Phase II Award, February 2021	A STTR Phase II contract was awarded to NUBAD, LLC in February, 2021 for $999,985.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ NUBAD, LLC	National Institutes of Health	STTR	2R42AI114114-03	Phase II	999,985	February 10, 2021	sbir.gov/node/2185713
‌ COLLABORATIONS PHARMACEUTICALS, INC. SBIR Phase I Award, September 2018	A SBIR Phase I contract was awarded to Collaborations Pharmaceuticals in September, 2018 for $411,523.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Collaborations Pharmaceuticals	National Institutes of Health	SBIR	1R43NS107079-01	Phase I	411,523	September 15, 2018	sbir.gov/node/1567481
‌ Inscopix, Inc. SBIR Phase II Award, September 2019	A SBIR Phase II contract was awarded to Inscopix, Inc. in September, 2019 for $629,800.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Inscopix, Inc.	National Institutes of Health	SBIR	4R44MH118752-02	Phase II	629,800	September 1, 2019	sbir.gov/node/1682829
‌ Radiant Creative Group, LLC STTR Phase II Award, January 2021	A STTR Phase II contract was awarded to Radiant Creative Group, LLC in January, 2021 for $722,714.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Radiant Creative Group, LLC	National Institutes of Health	STTR	4R42HD100233-02	Phase II	722,714	January 15, 2021	sbir.gov/node/2184463
‌ APHIOS CORPORATION SBIR Phase II Award, July 2019	A SBIR Phase II contract was awarded to Aphios in July, 2019 for $1,558,277.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Aphios	National Institutes of Health	SBIR	4R44HL137605-02	Phase II	1,558,277	July 1, 2019	sbir.gov/node/1679935
‌ NUBAD, LLC STTR Phase II Award, March 2021	A STTR Phase II contract was awarded to NUBAD, LLC in March, 2021 for $999,986.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ NUBAD, LLC	National Institutes of Health	STTR	2R42AI126874-03	Phase II	999,986	March 19, 2021	sbir.gov/node/2186065
‌ SAFELYYOU INC. SBIR Phase I Award, September 2018	A SBIR Phase I contract was awarded to SafelyYou in September, 2018 for $484,916.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	SafelyYou	National Institutes of Health	SBIR	1R44AG062088-01	Phase I	484,916	September 30, 2018	sbir.gov/node/1572715
‌ PROVOC INC SBIR Phase I Award, September 2019	A SBIR Phase I contract was awarded to Provoc in September, 2019 for $327,980.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Provoc	National Institutes of Health	SBIR	1R43AG055218-01A1	Phase I	327,980	September 15, 2019	sbir.gov/node/1684931
‌ COLLABORATIONS PHARMACEUTICALS, INC. SBIR Phase II Award, September 2021	A SBIR Phase II contract was awarded to Collaborations Pharmaceuticals in September, 2021 for $855,127.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Collaborations Pharmaceuticals	National Institutes of Health	SBIR	2R44GM122196-04A1	Phase II	855,127	September 1, 2021	sbir.gov/node/2189561
‌ Inscopix, Inc. SBIR Phase I Award, September 2018	A SBIR Phase I contract was awarded to Inscopix, Inc. in September, 2018 for $244,188.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Inscopix, Inc.	National Institutes of Health	SBIR	1R44MH118752-01	Phase I	244,188	September 18, 2018	sbir.gov/node/1572053
‌ Glycan Therapeutics Corporation SBIR Phase II Award, March 2020	A SBIR Phase II contract was awarded to Glycan Therapeutics in March, 2020 for $1,229,662.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Glycan Therapeutics	National Institutes of Health	SBIR	4R44GM134738-02	Phase II	1,229,662	March 1, 2020	sbir.gov/node/1910721

SBIR/STTR Award Recipient

Contract Number (US Government)

A STTR Phase II contract was awarded to NeoVative, Inc. in February, 2019 for $723,986.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

A SBIR Phase II contract was awarded to DEKK-TEC INC in September, 2018 for $759,848.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

A SBIR Phase II contract was awarded to Trophogen, Inc. in March, 2018 for $1,768,121.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

A SBIR Phase I contract was awarded to Solid Material Solutions, LLC in September, 2018 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

A SBIR Phase I contract was awarded to BENDER TECH, LLC in July, 2019 for $142,309.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

A SBIR Phase II contract was awarded to Neurowave Systems Inc. in September, 2019 for $663,684.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

A SBIR Phase II contract was awarded to Arima Genomics, Inc. in April, 2021 for $1,074,115.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

A SBIR Phase II contract was awarded to Arima Genomics, Inc. in September, 2021 for $1,085,125.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

A SBIR Phase II contract was awarded to Trophogen, Inc. in September, 2019 for $778,770.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

A SBIR Phase II contract was awarded to Arima Genomics, Inc. in March, 2018 for $1,747,389.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

A SBIR Phase I contract was awarded to Serina Therapeutics in September, 2019 for $1,658,634.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

A SBIR Phase II contract was awarded to SafelyYou in September, 2019 for $536,666.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

A SBIR Phase I contract was awarded to Trophogen, Inc. in August, 2018 for $285,070.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

A SBIR Phase I contract was awarded to Collaborations Pharmaceuticals in August, 2019 for $68,862.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

A STTR Phase II contract was awarded to NUBAD, LLC in February, 2021 for $999,985.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

A SBIR Phase I contract was awarded to Collaborations Pharmaceuticals in September, 2018 for $411,523.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

A SBIR Phase II contract was awarded to Inscopix, Inc. in September, 2019 for $629,800.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

A STTR Phase II contract was awarded to Radiant Creative Group, LLC in January, 2021 for $722,714.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

A SBIR Phase II contract was awarded to Aphios in July, 2019 for $1,558,277.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

A STTR Phase II contract was awarded to NUBAD, LLC in March, 2021 for $999,986.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

A SBIR Phase I contract was awarded to SafelyYou in September, 2018 for $484,916.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

A SBIR Phase I contract was awarded to Provoc in September, 2019 for $327,980.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

A SBIR Phase II contract was awarded to Collaborations Pharmaceuticals in September, 2021 for $855,127.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

A SBIR Phase I contract was awarded to Inscopix, Inc. in September, 2018 for $244,188.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

A SBIR Phase II contract was awarded to Glycan Therapeutics in March, 2020 for $1,229,662.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

...

Results per page:

8,409 results

0 selected

8,409 results

0 selected